Searched over 200M research papers
7 papers analyzed
These studies suggest that natural statins, primarily derived from fungi, are effective in lowering cholesterol levels, reducing coronary events, and have potential therapeutic uses in osteoporosis and cancer treatment, though their use requires careful consideration of benefit-risk ratios and drug interactions.
20 papers analyzed
Statins are a class of drugs widely used to lower cholesterol levels in the blood, thereby reducing the risk of heart attacks and strokes. They function by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in cholesterol biosynthesis. Natural statins are derived from fermentation processes involving various fungi, including Monascus spp., Penicillium spp., Aspergillus terreus, and Pleurotus ostreatus.
Natural statins such as lovastatin and compactin (mevastatin) are primarily produced through the fermentation of specific fungi. Lovastatin is mainly produced by Aspergillus terreus, while compactin is derived from Penicillium citrinum . These statins can be produced industrially using liquid submerged fermentation or solid-state fermentation, with the latter offering certain advantages.
Pravastatin is a natural statin obtained by the biotransformation of compactin using Streptomyces carbophilus. Simvastatin, a semi-synthetic derivative of lovastatin, is produced by modifying the lovastatin side chain through chemical processes. Advances in biochemistry and genetics have enabled the development of new methods for producing simvastatin, including the use of the enzyme acyltransferase LovD from Aspergillus terreus.
Natural statins, such as lovastatin and pravastatin, share a common polyketide structure with a hydroxy-hexahydro naphthalene ring system, to which different side chains are attached. Despite differences in their chemical structures, natural and synthetic statins exhibit similar pleiotropic and adverse effects, which are influenced by their pharmacokinetic parameters and chemical properties.
Statins are highly effective in lowering plasma cholesterol levels by inhibiting HMG-CoA reductase, which reduces the synthesis of endogenous cholesterol. This leads to a decrease in very low-density lipoproteins (VLDL) and low-density lipoproteins (LDL), and an increase in high-density lipoproteins (HDL), thereby reducing the LDL-to-HDL cholesterol ratio, a key predictor of atherogenic risk.
Beyond their cholesterol-lowering effects, statins have been reported to possess various biological activities, including immunomodulatory, anti-inflammatory, anti-angiogenic, and anti-proliferative functions. These effects are attributed to the inhibition of protein isoprenylation, which affects cell signal transduction pathways involving proteins such as Ras and RhoA.
Recent studies have suggested that statins may also play a role in increasing bone formation rates, raising the possibility of their use as anabolic agents for treating osteoporosis. This is particularly significant given the lack of currently available oral agents that can stimulate substantial new bone formation.
Natural statins, derived from fungal fermentation processes, have proven to be highly effective in lowering cholesterol levels and reducing the risk of cardiovascular diseases. Their production involves sophisticated biotechnological methods, including fermentation and biotransformation. In addition to their primary use, statins exhibit a range of biological activities that may have therapeutic potential in other areas, such as osteoporosis treatment. As research continues, the full scope of statins' benefits and mechanisms of action will likely be further elucidated, potentially leading to new applications and improved formulations.
Most relevant research papers on this topic